All Stories

  1. The safer chemical design game. Gamification of green chemistry and safer chemical design concepts for high school and undergraduate students
  2. Pharmaceutical bioaccumulation by periphyton and snails in an effluent-dependent stream during an extreme drought
  3. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research
  4. Exposure and food web transfer of pharmaceuticals in ospreys (Pandion haliaetus): Predictive model and empirical data
  5. International scientists' priorities for research on pharmaceutical and personal care products in the environment
  6. Reducing aquatic hazards of industrial chemicals: Probabilistic assessment of sustainable molecular design guidelines
  7. Fish on Prozac (and Zoloft): Ten years later
  8. Chronic fluoxetine exposure alters movement and burrowing in adult freshwater mussels
  9. An exploratory investigation of various modes of action and potential adverse outcomes of fluoxetine in marine mussels
  10. Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments
  11. Development and application of a novel method for high‐throughput determination of PCDD/Fs and PCBs in sediments
  12. Assessment of Mosquitofish (Gambusia affinis) Health Indicators in Relation to Domestic Wastewater Discharges in Suburbs of Houston, USA
  13. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent
  14. Selective Pressurized Liquid Extraction Technique Capable of Analyzing Dioxins, Furans, and PCBs in Clams and Crab Tissue
  15. Interplay between ambient surface water mixing and manipulated hydraulic flushing: Implications for harmful algal bloom mitigation
  16. Ammonium treatments to suppress toxic blooms of Prymnesium parvum in a subtropical lake of semi-arid climate: Results from in situ mesocosm experiments
  17. Enantiomer‐Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)
  18. Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions
  19. Comparative analysis of effluent water quality from a municipal treatment plant and two on-site wastewater treatment systems
  20. Nutrient stoichiometry and concentrations influence silver toxicity in the aquatic macrophyte Lemna gibba
  21. Toward sustainable environmental quality: A call to prioritize global research needs
  22. Sublethal silver and NaCl toxicity in Daphnia magna: a comparative study of standardized chronic endpoints and progeny phototaxis
  23. Beyond hydraulic flushing: Deep water mixing takes the harm out of a haptophyte algal bloom
  24. Low pH preempts bloom development of a toxic haptophyte
  25. Anticipated human population and climate change effects on algal blooms of a toxic haptophyte in the south-central USA1This article is derived from a special session entitled “A New Hydrology: Inflow Effects on Ecosystem Form and Functioning...
  26. Occurrence of Pharmaceuticals and Personal Care Products in German Fish Tissue: A National Study
  27. STIMULATING EFFECT OF ANABAENA SP. (CYANOBACTERIA) EXUDATE ON PRYMNESIUM PARVUM (HAPTOPHYTA)1
  28. Human Therapeutic Plasma Levels of the Selective Serotonin Reuptake Inhibitor (SSRI) Sertraline Decrease Serotonin Reuptake Transporter Binding and Shelter-Seeking Behavior in Adult Male Fathead Minnows
  29. Modeling of plankton community dynamics characterized by algal toxicity and allelopathy: A focus on historical Prymnesium parvum blooms in a Texas reservoir
  30. Human Pharmaceuticals in the Environment
  31. Towards rational molecular design for reduced chronic aquatic toxicity
  32. Considerations and Criteria for the Incorporation of Mechanistic Sublethal Endpoints into Environmental Risk Assessment for Biologically Active Compounds
  33. Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions
  34. Perspectives on Human Pharmaceuticals in the Environment
  35. Human Pharmaceuticals in the Aquatic Environment: A Review of Recent Toxicological Studies and Considerations for Toxicity Testing
  36. Prymnesium parvum: An emerging threat to inland waters
  37. Influence of drought and total phosphorus on diel pH in wadeable streams: Implications for ecological risk assessment of ionizable contaminants
  38. Effects of the antihistamine diphenhydramine on selected aquatic organisms
  39. The challenges posed by radiation and radionuclide releases to the environment
  40. Application of chemical toxicity distributions to ecotoxicology data requirements under REACH
  41. PBDE developmental effects on embryonic zebrafish
  42. An initial probabilistic hazard assessment of oil dispersants approved by the united states national contingency plan
  43. Aquatic uptake of drug residues from the environment
  44. Fate of Sucralose through Environmental and Water Treatment Processes and Impact on Plant Indicator Species
  45. Towards rational molecular design: derivation of property guidelines for reduced acute aquatic toxicity
  46. Conservation Physiology of the Plethodontid Salamanders Eurycea nana and E. sosorum: Response to Declining Dissolved Oxygen
  47. Carbon sink to source: longitudinal gradients of planktonic P:R ratios in subtropical reservoirs
  48. Lake Granbury and Lake Whitney Assessment Initiative Final Scientific/Technical Report Summary
  49. Exploring Lemna gibba thresholds to nutrient and chemical stressors: Differential effects of triclosan on internal stoichiometry and nitrate uptake across a nitrogen:phosphorus gradient
  50. Chemical risk assessment: Pressures, perceptions and expectations
  51. A mechanistic explanation for pH-dependent ambient aquatic toxicity of Prymnesium parvum carter
  52. Influence of pH on amine toxicology and implications for harmful algal bloom ecology
  53. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals
  54. Hydraulic flushing as a Prymnesium parvum bloom-terminating mechanism in a subtropical lake
  55. Current Status of Mathematical Models for Population Dynamics of Prymnesium parvum in a Texas Reservoir1
  56. Factors Influencing Prymnesium parvum Population Dynamics During Bloom Initiation: Results from In‐lake Mesocosm Experiments1
  57. Hemolysis, Fish Mortality, and LC‐ESI‐MS of Cultured Crude and Fractionated Golden Alga (Prymnesium parvum)1
  58. Prymnesium parvum Population Dynamics During Bloom Development: A Role Assessment of Grazers and Virus1
  59. Comparative Toxicity ofPrymnesium parvumin Inland Waters1
  60. Probabilistic ecological hazard assessment of parabens using Daphnia magna and Pimephales promelas
  61. Pharmaceuticals and personal care products: Research needs for the next decade
  62. Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH
  63. Influence of nitrogen and phosphorus concentrations and ratios on Lemna gibba growth responses to triclosan in laboratory and stream mesocosm experiments
  64. Occurrence of pharmaceuticals and personal care products in fish: Results of a national pilot study in the united states
  65. Growth at the edge of the niche: An experimental study of the harmful alga Prymnesium parvum
  66. Perspectives on ecological risk assessment of chiral compounds
  67. River–reservoir transition zones are nitrogen fixation hot spots regardless of ecosystem trophic state
  68. Gas chromatography–mass spectrometry screening methods for select UV filters, synthetic musks, alkylphenols, an antimicrobial agent, and an insect repellent in fish
  69. Comparison of the sensitivities of common in vitro and in vivo assays of estrogenic activity: Application of chemical toxicity distributions
  70. Herbicidal Effects of Sulfamethoxazole in Lemna gibba: Using p-Aminobenzoic Acid As a Biomarker of Effect
  71. Assessing the Aquatic Hazards of Veterinary Medicines
  72. Environmental Risk Assessment and Management of Veterinary Medicines
  73. Physical Factors Control Phytoplankton Production and Nitrogen Fixation in Eight Texas Reservoirs
  74. Aquatic Plants Exposed to Pharmaceuticals: Effects and Risks
  75. Repeating History: Pharmaceuticals in the Environment
  76. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate
  77. [3H] Citalopram Binding to Serotonin Transporter Sites in Minnow Brains
  78. Daphnia magna responses to a vertebrate estrogen receptor agonist and an antagonist: A multigenerational study
  79. Laboratory tests of ammonium and barley straw extract as agents to suppress abundance of the harmful alga Prymnesium parvum and its toxicity to fish
  80. GROWTH AND TOXICITY OFPRYMNESIUM PARVUM(HAPTOPHYTA) AS A FUNCTION OF SALINITY, LIGHT, AND TEMPERATURE1
  81. Analysis of Pharmaceuticals in Fish Using Liquid Chromatography-Tandem Mass Spectrometry
  82. Enantiospecific toxicity of the β‐blocker propranolol to Daphnia magna and Pimephales promelas
  83. Physiological and Reproductive Effects of Beta Adrenergic Receptor Antagonists in Daphnia magna
  84. Water Quality of Effluent-dominated Ecosystems: Ecotoxicological, Hydrological, and Management Considerations
  85. A comparison of chronic cadmium effects on Hyalella azteca in effluent‐dominated stream mesocosms to similar laboratory exposures in effluent and reconstituted hard water
  86. Determination of select antidepressants in fish from an effluent‐dominated stream
  87. Reproductive Assessment of Japanese Medaka (Oryzias latipes) Following a Four-Week Fluoxetine (SSRI) Exposure
  88. Laboratory and field responses to cadmium: An experimental study in effluent‐dominated stream mesocosms
  89. Waterborne and sediment toxicity of fluoxetine to select organisms
  90. Aquatic ecotoxicology of fluoxetine
  91. Response of Ceriodaphnia dubia to ionic silver: discrepancies among model predictions, measured concentrations and mortality